Carcinex, Inc.

Boulder, CO 80301

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $100K
First Award Date 09/30/97
Most Recent Award Date 07/01/00

Key Personnel

Last Name Name Awards Contact
Chan Daniel C. Chan 2

2 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/00 - 06/30/02

This project is to develop small non-peptide molecules that mimic the structures and functions of a novel bradykinin antagonist dimer B201 and kill human, lung cancer cells specifically and effectively via a unique "biased-agonist" mechanism. "Biased-agonists" are receptor-mediated and inhibit the growth of lung cancer cells by inducing apoptoti...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/97 - 10/31/98

This project is designed to develop new agents with dual anti-angiogenic and cytotoxic properties for the chemoprevention and treatment of human lung cancers. Our strategy is to simultaneously attack the endothelial cells of the tumor vascular bed and the tumor cells using a series of novel peptide antagonis...